Home
Business
Stock Market
This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy

November 14, 2025nileshsha@hotmail.com

This is why Merck is buying Cidara Therapeutics for .2 billion, and why Wall Street is happy

Merck is facing a patent cliff for Keytruda and upheaval in the market for Gardasil.

www.marketwatch.com
#Merck #buying #Cidara #Therapeutics #billion #Wall #Street #happy

Related reading:

Reed Hastings created a work culture that made Netflix a giant. Can it survive without him?
This high yield bond fund just hit a sweet spot, but timing matters
The 3 forces that drove a remarkable, record-setting week on Wall Street

Share: X · Facebook · LinkedIn